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Abstract
RNA silencing pathways play critical roles in gene regulation, virus infection, and transposon control. RNA interference
(RNAi) is mediated by small interfering RNAs (siRNAs), which are liberated from double-stranded (ds)RNA precursors by
Dicer and guide the RNA-induced silencing complex (RISC) to targets. Although principles governing small RNA sorting into
RISC have been uncovered, the spectrum of RNA species that can be targeted by Dicer proteins, particularly the viral RNAs
present during an infection, are poorly understood. Dicer-2 potently restricts viral infection in insects by generating virus-
derived siRNAs from viral RNA. To better characterize the substrates of Dicer-2, we examined the virus-derived siRNAs
produced during the Drosophila antiviral RNAi response to four different viruses using high-throughput sequencing. We
found that each virus was uniquely targeted by the RNAi pathway; dicing substrates included dsRNA replication
intermediates and intramolecular RNA stem loops. For instance, a putative intergenic RNA hairpin encoded by Rift Valley
Fever virus generates abundant small RNAs in both Drosophila and mosquito cells, while repetitive sequences within the
genomic termini of Vaccinia virus, which give rise to abundant small RNAs in Drosophila, were found to be transcribed in
both insect and mammalian cells. Moreover, we provide evidence that the RNA species targeted by Dicer-2 can be
modulated by the presence of a viral suppressor of RNAi. This study uncovered several novel, heavily targeted features
within viral genomes, offering insight into viral replication, viral immune evasion strategies, and the mechanism of antiviral
RNAi.
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Introduction
RNA silencing pathways are critical regulators of gene
expression in organisms ranging from yeast to humans. RNA
silencing is initiated by the action of RNase III enzymes, which
target RNAs with dsRNA character to generate small RNA
duplexes [1]. Following biogenesis, small RNA sorting directs the
selection of one strand of the duplex to be retained and stabilized
by an Argonaute family member in RISC [2]. The RNA silencing
pathways of Drosophila melanogaster have been extensively charac-
terized and allow for detailed dissection of the mechanisms
governing RNAi-mediated gene silencing. The siRNA silencing
pathway is responsible for controlling the expression of both
endogenous and exogenous targets in somatic cells. siRNA
biogenesis is carried out by Dicer-2 (Dcr-2), which generates
predominantly 21 nucleotide (nt) products from several types of
precursors [3]. Endogenous siRNAs (esiRNAs) are generated from
long hairpins, retrotransposons or convergent transcription units
and regulate endogenous gene expression, while exogenous
siRNAs (exo-siRNAs) are processed from long dsRNAs, a process
commonly manipulated in molecular biology to achieve targeted
gene silencing [1]. In addition, virus-derived siRNAs (vsiRNAs)
are cleaved from viral RNAs produced during infection [4]. The
miRNA pathway generates mature miRNAs from stem-loop
structures within pri-miRNA transcripts through a series of RNase
III cleavage events; Drosha first liberates the pre-miRNA from the
primary transcript, then Dicer-1 (Dcr-1) generates the mature
product, generally 22–23 nt in length [1]. The piRNA pathway,
active predominantly in the germline, targets transposon-derived
RNAs to produce 24–29 nt piRNAs, although the enzymatic
processing and secondary structure of piRNA pathway substrates
is poorly understood [1,2].
In Drosophila, siRNAs are preferentially loaded into Argonaute 2
(Ago2), while miRNAs predominantly bind Argonaute 1 (Ago1)
[2,3]. piRNAs are bound by piwi, aubergine and Ago3 complexes
[1]. Several properties contribute to small RNA sorting into
Argonaute complexes in Drosophila, including the thermodynamic
characteristics of the small RNA duplex, specific terminal
nucleotide sequences, and the extent of central mismatches or
pairing within the duplex [2,4]. However, the properties governing
Dcr-2-mediated siRNA biogenesis and dsRNA processing have
not been extensively characterized.
Many invertebrates such as plants, insects and C. elegans utilize
the activity of RNA silencing pathways to degrade viral RNAs and
thus limit virus infection [4,5]. Antiviral RNAi restricts viral
infection at two steps, first through viral RNA cleavage by Dicer
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Figure 1. VSV vsiRNAs are concentrated at the 59 genomic terminus. (A) RNA species produced during VSV infection. (2) strand genome is
depicted in blue, (+) strand antigenome and mRNAs in red. (B) VSV vsiRNA size distribution (control library). (C) Distribution of 21 nt VSV vsiRNAs
across the viral genome. vsiRNAs mapping to genomic strand are depicted in blue, antigenomic strand in red. (D) VSV vsiRNA size distribution
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enzymes to generate vsiRNAs, and secondly through the targeting
of viral RNAs by RISC. Numerous medically important viruses
are transmitted to humans by insects and are therefore termed
arboviruses (arthropod-borne viruses), and studies of natural
mosquito vectors have demonstrated that the RNAi pathway is
a critical component of the insect antiviral response toward these
RNA viruses [6–11]. Therefore, uncovering the mechanism of
antiviral RNAi is essential to understand the pathogenesis of
arboviral infections in insect hosts. Drosophila has provided an
excellent model for the study of antiviral RNAi, due in part to the
fact that the organism is readily infected by a diverse panel of
viruses and that its small RNA silencing pathways are well-
characterized [1,12].
Since the Drosophila siRNA pathway is both antiviral and
exquisitely poised to recognize dsRNA, the prevailing view is that
viral dsRNAs generated during replication of RNA viruses are the
target of the antiviral silencing system [4,6] and are thought to
represent the Pathogen Associated Molecular Patterns or PAMPs
for this innate defense program. Thus, Dcr-2 is the Pattern
Recognition Receptor or PRR responsible for targeting the viral
PAMPs to induce the antiviral program. In order to better
understand the mechanisms by which RNA silencing is antiviral in
insects, and to uncover the viral RNA PAMPs that are specifically
targeted by the PRR Dcr-2, we used high-throughput small RNA
sequencing to characterize the vsiRNAs produced during infection
of Drosophila cells. We sequenced the small RNAs generated from
three RNA viruses with different coding strategies, and one DNA
virus. The viruses include the rhabdovirus Vesicular Stomatitis
virus (VSV), the human arbovirus Rift Valley Fever virus (RVFV),
the natural Drosophila picorna-like virus Drosophila C virus (DCV),
and the dsDNA poxvirus Vaccinia virus (VACV). By studying the
antiviral targeting of this diverse set of viruses, we found common
features of viral RNA that are preferentially targeted by the
cellular machinery, along with novel, heavily targeted viral RNA
structures that have not previously been characterized in either
RNA or DNA viruses.
Results
The Antiviral RNAi Pathway Targets VSV dsRNA
Replication Intermediates
VSV is a rhabdovirus that is naturally transmitted to vertebrates
by biting flies, readily infects Drosophila, and serves as a model for
medically important pathogens such as measles, rabies, and Ebola
virus [13]. The virus contains an 11 kb (2) sense RNA genome
that is replicated using a (+) sense antigenome as a template
(Figure 1A). Viral proteins are encoded by individual subgenomic
mRNAs, which are transcribed via a stop-start mechanism
resulting in a gradient of messages, with the most abundant
messages mapping to the 39 end of the genome [1,13]. VSV is
potently restricted by RNA silencing [2,12,14]. We employed high
throughput small RNA sequencing to characterize the vsiRNAs
produced during VSV infection of Drosophila cells. We found that
the majority of VSV vsiRNAs are 21 nt in length (Figure 1B),
which is the expected size of Dcr-2 cleavage products that are
active in an Ago2-containing RISC. To identify the genomic
regions that give rise to these vsiRNAs, we mapped the 21 nt
vsiRNAs onto the VSV genome and antigenome sequences, and
found that the vsiRNAs are approximately evenly distributed
between the genomic and antigenomic strands at a ratio of 1.2:1.
Remarkably, the majority of these vsiRNAs cluster in a discrete
,1.6 kb region at the 59 end of the genome (Figure 1C). A similar
distribution pattern is observed when the remaining non-21 nt
vsiRNAs are mapped onto the VSV genome; however, non-21 nt
species are much less abundant (Figure S1A).
To further define the mechanism of virus restriction by antiviral
RNAi, we examined the contribution of known components of
Drosophila RNA silencing pathways to the observed VSV vsiRNA
size distributions and genomic mapping patterns. To address
vsiRNA biogenesis, we depleted cells of the three somatic RNase
III enzymes Dcr-2, Dcr-1 and Drosha, challenged them with VSV,
and characterized the vsiRNAs produced. Functional depletion
was confirmed by small RNA northern blotting and qPCR (Figure
S2). Consistent with our hypothesis that most VSV vsiRNAs are
generated by Dcr-2, loss of this factor nearly abolished all vsiRNA
biogenesis (14.2-fold decrease) (Figure 1D). The magnitude of this
effect is particularly striking when examining the extensively
targeted 1 kb region at the 59 terminus of the genome (Figure 1E,
compare black and green traces). In contrast, Dcr-1 and Drosha
depletion does not greatly alter VSV vsiRNA levels (Figures 1D–
E).
To examine the contribution of RISC loading and stabilization
to steady state vsiRNA levels, we analyzed the spectrum of VSV
vsiRNAs from cells depleted of the somatic Argonautes Ago2 and
Ago1. miRNA RISC component Ago1 has little influence on the
vsiRNA size distribution and mapping pattern, as expected
(Figures 1F–G). Although depletion of the siRNA pathway slicer,
Ago2, does not appear to greatly reduce the bulk levels of 21 nt
vsiRNAs (Figure 1F), its effect is clear when the vsiRNAs are
plotted against the VSV genome. Loss of Ago2 significantly
reduces the steady-state levels of vsiRNAs deriving from the
majority of the genome, but has no effect on the abundant
vsiRNAs mapping to the extensively targeted region at the 59
terminus (Figure 1G).
Dcr-2 Targets VSV-derived DI Hairpins
The striking differences in vsiRNA levels derived from the VSV
59 terminus relative to the rest of the genome led us to dissect this
disparity in greater detail. We therefore divided the VSV genome
into two regions; nt 1–9499, which is targeted at relatively low
levels, and nt 9500–11161, which generates abundant vsiRNAs.
VSV vsiRNAs from Dcr-2 and Ago2-depleted cells were then
plotted relative to vsiRNAs from control cells (Figure 2A), and the
absolute number of vsiRNAs mapping to each region were
quantified across VSV libraries (Figure 2B). Although the heavily
targeted region only comprises ,15% of the VSV genome
sequence, it produces an equal number of vsiRNAs as the rest of
the genome in the control, Dcr-1 and Ago1 depleted libraries
(Figure 2A). Loss of Dcr-2 nearly abolishes all vsiRNA biogenesis
from both regions (Figures 2A–B). In contrast, knockdown of Ago2
selectively depletes vsiRNAs from nt 1–9499, while the levels of
vsiRNAs from nt 9500–11161 are increased by ,35%, implying
that the vsiRNAs derived from the heavily targeted region are not
loaded into Ago2 and thus do not require Ago2 for stability
(Figures 2A–B). Taken together, these data suggest that although
between libraries depleted of RNase III enzymes. (E) Effect of RNase III enzyme depletion on 21 nt VSV vsiRNAs. vsiRNAs from control (black), Dcr-1
(orange), Dcr-2 (green) and Drosha (blue) depleted cells are compared. (F) VSV vsiRNA size distribution between libraries depleted of Argonaute
proteins. (G) Effect of Argonaute depletion on 21 nt VSV vsiRNAs. vsiRNAs from control (black), Ago1 (orange), and Ago2 (green) depleted cells are
compared. See also Figures S1, S2.
doi:10.1371/journal.pone.0055458.g001
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the vast majority of VSV vsiRNAs are produced by Dcr-2, only
a particular subset is loaded into Ago2.
These findings also imply that the region that produces
abundant vsiRNAs is distinct from the rest of the genome. The
heavily targeted region lies within the polymerase (L) coding
sequence, but the L mRNA is over 6 kb in length (Figure S3),
which cannot account for the discrete targeting of only a ,1.5 kb
stretch. However, VSV is known to generate several types of
defective interfering (DI) particles, which contain only small
portions of the parental genome and can interfere with parental
Figure 2. VSV DI particles produce vsiRNAs that are insensitive to RISC depletion. (A) Distribution of vsiRNAs generated from two distinct
regions of the VSV genome (nt 1–9499 versus nt 9500–11161) during infection of control cells (black), Ago2-depleted cells (dashed green), and Dcr-2-
depleted cells (solid green). (B) Comparison of relative numbers of vsiRNAs mapping to the two regions between libraries, normalized to total library
reads. (C) Northern blot analysis of VSV-infected Drosophila cells. Strand-specific oligonucleotide probes include (+) sense oligos that recognize
genome-sense RNAs either within the heavily targeted region (green) or in the poorly targeted region (blue), and a (2) sense oligo that recognizes
antigenomic RNAs within the heavily targeted region (red). A 600 nt probe (purple) recognizes both (+) and (2) sense RNAs within the heavily
targeted region. Arrow indicates 6 kb L mRNA (see Figure S3 for darker exposure).
doi:10.1371/journal.pone.0055458.g002
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virus replication [3,13]. One class of DI particles are termed
snapback or hairpin particles and are comprised of perfectly
complementary sequences derived from the VSV 59 terminus
[1,15]. We therefore hypothesized that a snapback DI particle was
the source of the abundant VSV vsiRNAs. Strand-specific
oligonucleotide probes directed against the heavily targeted 59
region were used to probe a northern blot of RNA from VSV-
infected Drosophila cells (Figure 2C, red and green probes). Both the
sense and antisense probes recognized a novel ,1.5 kb band,
while an additional probe that recognizes a sequence upstream of
the heavily targeted region did not yield a signal (Figure 2C, blue
probe). An internally labeled PCR probe designed to detect the L
mRNA also recognizes the putative ,1.5 kb DI RNA, which is
present at much higher levels than the L transcript (arrow,
Figures 2C, S3). These data suggest that the extensive targeting of
the VSV 59 terminal region may be due to the presence of a highly
expressed replicating RNA that is likely a self-complementary DI
particle.
RVFV Infection Generates Abundant vsiRNAs from
Genomic and Antigenomic RNA Strands
RVFV is a member of the Bunyaviridae family, one of the main
classes of medically relevant arboviruses. RVFV carries a ,12 kb
trisegmented negative sense genome comprised of the large (L)
medium (M) and small (S) segments (Figure 3A). While both the L
and M segments encode transcripts in the sense orientation, the S
segment encodes two distinct gene products using an ambisense
coding strategy [4,16]. RVFV infects Drosophila and is restricted
by the RNA silencing machinery ([1,17], data not shown). We
found that the majority of RVFV vsiRNAs are 21 nt in length
(Figure 3B). The vsiRNAs derived from the L and M segments are
present in approximately equal ratios (1.3:1) between the (+) and
(2) strands, and are distributed in a uniform manner across the
genomic segments (Figures 3C, S1D). This suggests that the L and
M segments are targeted at the level of the replicating viral
dsRNA. In contrast, the S segment contains a vsiRNA hotspot
within a particular region of the antigenome, suggesting a distinct
mode of recognition or processing (Figure 3C).
To determine whether RVFV is recognized and processed by
the siRNA pathway, RVFV vsiRNA size classes and genomic
mapping were characterized following depletion of RNA silencing
components. Functional depletion was confirmed by small RNA
northern blotting (Figure S2). Loss of Dcr-2 affects all vsiRNA size
classes, most notably the levels of 21 nt RVFV vsiRNAs
(Figure 3D). The Dcr-2 dependence of RVFV vsiRNAs is
particularly evident when the vsiRNAs are mapped onto the viral
genomic segments (Figure 3E; compare black and green traces).
Knockdown of miRNA components Dcr-1 and Drosha slightly
suppresses vsiRNA biogenesis, albeit to a lesser degree than Dcr-2
depletion. Similar to Dcr-2, loss of Ago2 leads to a reduction in
21 nt vsiRNAs (Figures 3F–G). Ago1 depletion slightly reduces
vsiRNA levels across all size classes (Figures 3F–G), but its effect on
the 21 nt species is not as strong as loss of Ago2.
RVFV Contains a Putative Intergenic RNA Hairpin
While we noted that the RVFV L and M segment vsiRNAs
were evenly derived from the genome and antigenome, and evenly
distributed across their lengths, the S segment appeared to be
uniquely targeted. A large fraction (37.8%) of total RVFV
vsiRNAs mapped to a particular region in the S segment
antigenome (Figure 3C). Specifically, two 21 nt vsiRNAs and
two 22 nt vsiRNAs derived from within the S segment intergenic
region (IGR) are extremely abundant in the library. Interestingly,
the S segment IGR is thought to fold into an RNA hairpin in
several bunyaviruses [1,16], and RNAfold predicts the presence of
a hairpin within this sequence (Figure 4A). The abundant S
segment vsiRNAs map within the predicted stem region
(Figure 4A, red) and are readily detected by small RNA Northern
blotting of infected Drosophila cells (Figure 4B). To determine
whether this putative hairpin is targeted during infection of
mosquitoes, which are responsible for natural transmission of the
virus, we challenged two mosquito cell lines with RVFV: Aedes
aegypti Aag2 cells and Aedes albopictus C6/36 cells. Small RNA
northern blotting revealed that the vsiRNAs derived from the
putative intergenic hairpin are highly abundant in RVFV-infected
Aag2 and C6/36 cells but not uninfected cells (Figure 4B).
Although C6/36 cells have been shown to have a defective siRNA
pathway [2,18], the biogenesis of these abundant vsiRNAs is
unaltered in these cells, which may suggest that other cellular or
viral proteins are involved in their production. This is also
supported by our observation that knockdown of Dcr-2 does not
completely abolish their production (Figure 3E). Thus, in the case
of RVFV, the most abundant vsiRNAs are not produced from
a dsRNA replication intermediate, but instead derive from
a discrete intergenic region that likely forms a structured viral
RNA hairpin. In other bunyaviruses, S segment intergenic
hairpins play essential roles in viral RNA replication, indicating
the necessity to conserve this structure despite the presence of an
antiviral RNAi response [1,16].
The DCV vsiRNA Distribution Reflects Extensive Targeting
of Single Stranded Genomic RNA
As a natural Drosophila pathogen that has co-evolved with the
host, we hypothesized that the antiviral pathway may be uniquely
poised to restrict DCV replication. Indeed, RNAi pathway
components are potently antiviral against DCV [2,19,20]. DCV
encodes a 9.3 kb positive-stranded genome that contains two
internal ribosome entry sites (IRESs) that are highly structured,
and no subgenomic transcripts (Figure 5A) [4,5,21]. Analysis of the
small RNAs from DCV-infected Drosophila cells revealed that
vsiRNAs are predominantly 21 nt in length (Figure 5B). Strikingly,
the majority of 21 nt (Figure 5C) and non-21 nt (Figure S1B)
DCV vsiRNAs map to the genomic (+) strand (87.4%). The
preferential targeting of genomic RNA is consistent both with
previous studies of DCV vsiRNA patterns in a different Drosophila
cell line [6–11,22], and with infection of adult flies by wild-type
Flock House virus (FHV), another insect pathogen [1,12,23]. The
unequal skewing of DCV vsiRNAs to the (+) strand could be
a result of Dcr-2 processing of structured regions and hairpins
within the abundant single-stranded genomic (+) strand RNA, or
the skewing could be due to enhanced stability of (+) strand-
derived vsiRNAs processed from dsRNA replication intermedi-
ates. Although some of the (+) strand DCV vsiRNAs may simply
be degradation products of the abundant genome strand RNAs,
the majority are 21 nt in length, suggesting that they are bona-fide
Dcr-2 products. Due to their extensive secondary structure, we
expected the two viral IRES structures to be extensively targeted
by the antiviral machinery. However, this is not the case; although
several regions of the DCV genome appear to be ‘‘hot spots’’ for
vsiRNA biogenesis, these regions do not fall within the IRES
sequences.
To further study the production of DCV vsiRNAs, we depleted
the enzymes involved in RNA silencing and confirmed functional
depletion by small RNA northern blotting (Figure S2). Knock-
down of Dcr-2 leads to a striking reduction of 21 nt vsiRNAs,
demonstrating that the skewed (+) strand bias is not simply due to
random degradation of genomic RNAs (Figures 5D, E). In
contrast to Dcr-2, depletion of miRNA pathway components Dcr-
Dicer-2 Processes Diverse Viral RNA Species
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Figure 3. Both the genomic and antigenomic RNA strands of the arbovirus RVFV generate vsiRNAs. (A) RNA species produced during
RVFV infection. (2) strand genomic segments and mRNAs are depicted in blue, (+) strand antigenomes and mRNAs in red. (B) RVFV vsiRNA size
distribution (control library). (C) Distribution of 21 nt RVFV vsiRNAs across the three viral genomic segments. vsiRNAs mapping to genomic strand are
depicted in blue, antigenomic strand in red. (D) RVFV vsiRNA size distribution between libraries depleted of RNase III enzymes. (E) Effect of RNase III
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1 and Drosha do not affect the spectrum of 21 nt DCV vsiRNAs
(Figures 5D–E).
Next, we assessed the role of RISC components in generating
the DCV vsiRNA spectrum. Knockdown of Ago2 results in
a reduction in all vsiRNA size classes, particularly 21 nt vsiRNAs,
while loss of Ago1 has variable effects on each size class (Figure 5F).
Although neither knockdown affects the vsiRNA distribution
pattern across the DCV genome, the magnitudes of vsiRNA
hotspots are reduced by Ago2 depletion (Figure 5G), suggesting
that 21 nt DCV vsiRNAs are loaded into Ago2, and the loss of this
factor leads to their destabilization. Altogether, these data suggest
that DCV vsiRNAs are predominantly generated and stabilized by
the canonical siRNA pathway components Dcr-2 and Ago2,
consistent with the pathway’s known role in antiviral defense.
However, rather than the viral dsRNA intermediate, it is the viral
genomic RNA that is responsible for generating the majority of
DCV vsiRNAs.
DCV Infection Alters Dcr-2 Processing
Our observation that VSV and RVFV vsiRNAs are derived
from genomic and antigenomic RNA strands in approximately
equal ratios led us to postulate that this distribution pattern reflects
targeting of dsRNA replication intermediates. In contrast, the
DCV vsiRNA distribution is strikingly different than that of VSV
or RVFV; the majority of DCV vsiRNAs map exclusively to the
genomic RNA strand, suggesting that the dsRNA replication
intermediate is not the primary Dcr-2 target. Interestingly, DCV
encodes an RNAi suppressor, DCV-1A, which binds dsRNA and
is therefore thought to protect the DCV dsRNA replication
intermediate during infection [4,6,20]. Therefore, we reasoned
that the skewed vsiRNA distribution pattern may be due to the
presence of DCV-1A; if the viral dsRNA replication intermediate
is protected by binding to DCV-1A, the antiviral machinery may
be forced to target other viral RNA species. Neither VSV nor
RVFV are known to carry a suppressor of RNAi, which could, in
enzyme depletion on 21 nt RVFV vsiRNAs. vsiRNAs from control (black), Dcr-1 (orange), Dcr-2 (green) and Drosha (blue) depleted cells are compared.
(F) RVFV vsiRNA size distribution between libraries depleted of Argonaute proteins. (G) Effect of Argonaute depletion on 21 nt RVFV vsiRNAs. vsiRNAs
from control (black), Ago1 (orange), and Ago2 (green) depleted cells are compared. See also Figures S1, S2.
doi:10.1371/journal.pone.0055458.g003
Figure 4. A putative hairpin within the RVFV S segment generates abundant vsiRNAs in Drosophila and mosquito cells. (A) RNA
secondary structure prediction of S segment IGR. The highly abundant vsiRNAs are mapped in red. (B) Northern blot analysis of RVFV-infected
Drosophila DL1 cells, Aedes aegypti Aag2 cells, and Aedes albopictus C6/36 cells, probed for the S segment stem loop vsiRNAs and tRNAval as a loading
control.
doi:10.1371/journal.pone.0055458.g004
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Figure 5. DCV genomic strand RNA is preferentially targeted by antiviral RNAi. (A) RNA species produced during DCV infection. (+) strand
genome is depicted in blue, (2) strand antigenome in red. (B) DCV vsiRNA size distribution (control library). (C) Distribution of 21 nt DCV-derived
vsiRNAs across the viral genome. vsiRNAs mapping to genomic strand are depicted in blue, antigenomic strand in red. (D) DCV vsiRNA size
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part, explain the ability of the RNAi machinery to target their
dsRNA replication intermediates. We thus reasoned that in the
absence of infection, synthetic dsRNAs bearing viral sequences
would be processed by the RNAi pathway to yield siRNAs that are
distributed equally between the positive and negative strands, We
examined the siRNAs produced in Drosophila cells bathed with an
in vitro synthesized GFP dsRNA, and compared them to the
vsiRNAs generated from VSV-encoded GFP, which is expressed
off of a subgenomic transcript during infection. Indeed, the
distribution pattern generated by bathing cells in GFP dsRNA
overlapped the distribution of VSV-derived GFP vsiRNAs and
was approximately equally distributed between both RNA strands
(Figure 6A, left). We then compared the relative abundance of
siRNAs generated from cells treated with a DCV-specific dsRNA
to the vsiRNA distribution pattern from the corresponding DCV
genomic region. The synthetic dsRNA bearing DCV sequences
generated siRNAs that mapped approximately equally to both
strands, in contrast to the DCV vsiRNAs produced during
infection, which are heavily skewed to the genomic (+) strand
(Figure 6A, right). These results support the hypothesis that VSV
(and by extension, RVFV) dsRNA replication intermediates are
targeted during vsiRNA biogenesis, while DCV replication
intermediates are not the primary targets of the antiviral
machinery.
To examine the potential role that DCV-1A may play in
influencing patterns of small RNA abundance, we asked whether
siRNA distributions from synthetic dsRNAs are skewed during
DCV infection, since DCV-1A could bind and protect them from
Dcr-2 processing. To test this, we examined the siRNAs produced
from LacZ dsRNA, which was used as a non-targeting control for
the VSV, RVFV and DCV libraries, and monitored the
distribution pattern of siRNAs generated from this exogenous
dsRNA. While the patterns of LacZ siRNAs produced during
VSV and RVFV infections are very similar (Figure 6B, solid and
dashed black lines), LacZ siRNAs produced during DCV infection
display a distinct distribution (Figure 6B, green). These results
support the notion that the RNAi suppressor protein DCV-1A
influences Dcr-2 targeting during DCV infection, and likely
explain the unequal distribution pattern of DCV vsiRNAs during
infection.
Viral and Synthetic dsRNAs Generate Reproducible
Patterns of Small RNAs
We noted that the individual peaks and troughs within the
vsiRNA mapping patterns were consistent between experiments,
and the distribution pattern of LacZ siRNAs produced in VSV
and RVFV infected cells appeared to be highly similar (Figure 6B),
suggesting that the distributions are a reproducible signature of
cellular targeting of RNA precursors rather than a result of
stochastic events. To quantify these observations, we compared the
abundance of LacZ dsRNA-derived siRNAs sequenced from
independent libraries. Raw reads for each individual LacZ siRNA
from the control VSV library were plotted against the LacZ
siRNA reads from the control RVFV library (data not shown).
The untransformed data exhibits increased variance at higher read
values, indicative of heteroscedasticity that can be stabilized by
proper transformation of the data. A Log2 transformation was
used for statistical inference (Figure 6C). Log2 transformed LacZ
siRNA counts show a significant degree of reproducibility between
libraries (R2 = 0.86; Figure 6C). These comparative analyses reveal
that a given dsRNA sequence generates a reproducible spectrum
of siRNAs when targeted by the Drosophila RNA silencing
machinery.
To dissect the specificity determinants of precursor RNAs
targeted by Dcr-2 that reproducibly give rise to high or low
abundance small RNAs, we began by examining the local
distribution of abundant small RNA peaks. We borrowed
a technique from time series analysis in which responses at time
t are compared to the immediately preceding responses; time t-1 is
designated as lag1, time t-2 as lag2, etc [13,24]. Thus, read counts
for 21-mers starting at each position in the precursor molecule
were compared with counts at neighboring sites. We identified
peaks of small RNA read counts in the data and examined the
surrounding positions for correlation. From a 6.7 kb subset of the
RVFV dataset (L and M segments), the distribution of counts
around the peaks shows clear clustering of 21-mers, with
significantly higher than background counts extending five
nucleotides up- and downstream of the peak (Figure 6D). To
determine whether this phenomenon could be extended to other
small RNA precursors, we computed the partial autocorrelation
functions of the abundant small RNAs from four sequences,
including two viral genomes and two exogenous dsRNAs
(Figure 6E). Autocorrelations can be used to assess whether the
abundance of one small RNA is related to the abundance of an
adjacent small RNA. For each precursor sequence, high autocor-
relation is seen at the lag 1, 2, and 3 positions (Figure 6E). In
addition, we observed a 21 nt lag that shows significant
autocorrelation (Figure 6E, black arrows), which suggests that at
least some of the small RNAs are processively cleaved from
precursor molecules at 21 nt intervals, a signature of Dcr-2
processing.
RNA Transcripts Produced by the DNA Virus VACV are
Dcr-2 Targets
VACV is a poxvirus closely related to Variola virus, the
causative agent of smallpox. VACV was selected as the sole DNA
virus in the panel because it replicates exclusively in the cytoplasm
(in contrast to other families of DNA viruses) and thus might be
unusually sensitive to cytoplasmic small RNA silencing pathways
[25]. The VACV genome is a ,200 kb dsDNA molecule with
covalently closed terminal loops (Figure 7A). VACV cannot
undergo a complete replication cycle in Drosophila cells but can
infect the cells and express early gene products [26]. We found
that VACV vsiRNAs are produced in infected Drosophila cells and
are predominantly 21 nt in length (Figure 7B). The 21 nt vsiRNAs
map to both the Watson and Crick strands of the virus, and are
particularly concentrated at the extreme genomic termini
(Figure 7C, black arrows). The non-21 nt vsiRNAs display
a similar distribution pattern, and also map abundantly to the
genomic termini (Figure S1C). We also noted several abundant
peaks of vsiRNAs that were distinct from the genomic termini.
One such region likely generates vsiRNAs through the targeting of
dsRNA produced by bidirectional transcription; a more detailed
diagram of the hot spot is provided in Figure S4A.
We reasoned that VACV vsiRNAs may be generated through
two mechanisms: bidirectional transcription at a particular locus
distribution between libraries depleted of RNase III enzymes. (E) Effect of RNase III enzyme depletion on 21 nt DCV vsiRNAs. vsiRNAs from control
(black), Dcr-1 (orange), Dcr-2 (green) and Drosha (blue) depleted cells are compared. (F) DCV vsiRNA size distribution between libraries depleted of
Argonaute proteins. (G) Effect of Argonaute depletion on 21 nt DCV vsiRNAs. vsiRNAs from control (black), Ago1 (orange), and Ago2 (green) depleted
cells are compared. See also Figures S1, S2.
doi:10.1371/journal.pone.0055458.g005
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Figure 6. Viral and synthetic dsRNA processing yields reproducible patterns of small RNA abundance. (A) Distribution of vsiRNAs
compared to synthetic dsRNA-derived siRNAs corresponding to VSV (left) or DCV (right). Virus-derived siRNAs are shown in black, synthetic dsRNA-
derived siRNAs are shown in red. (B) Distribution of siRNAs generated from LacZ dsRNA in cells infected with VSV (solid black), RVFV (dashed black) or
DCV (green). (C) Reproducibility of Log2-transformed 21 nt read counts from LacZ dsRNA present in VSV- or RVFV-infected cells. (D) Lagged response
data for RVFV M/L segment peaks. Distribution of logged counts upstream (positive lags) and downstream (negative lags) of position 1 of the peak
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could yield dsRNA that is processed into vsiRNAs, or structured
regions within single transcripts could be targeted by the RNA
silencing machinery or other cellular nucleases. Again, we
depleted the enzymes involved in RNA silencing and confirmed
functional depletion by small northern blotting (Figure S2). We
found that depletion of Dcr-2 led to a significant reduction in the
21 nt species, with a more modest effect on the other size classes
(Figure 7D). When mapped against the viral genome, the role of
Dcr-2 is clear; the peaks of abundant 21 nt vsiRNAs are nearly
abolished in the absence of Dcr-2 (Figure 7E, compare black and
green traces). Knockdown of miRNA component Dcr-1 does not
strongly deplete any vsiRNA size classes or influence their genomic
mapping pattern, but depletion of Drosha leads to an increase in
vsiRNA accumulation, particularly of the 21 nt species (Figure 7E).
We next assessed the contribution of the Argonautes Ago1 and
Ago2 to VACV vsiRNA levels. Unexpectedly, loss of siRNA RISC
component Ago2 increases both 21 nt and non-21 nt VACV
vsiRNAs (Figures 7F–G). Ago1 depletion also increases the levels
of 21 nt vsiRNAs, while the non-21 nt classes appear to be fairly
unaffected (Figures 7F–G).
Terminal Repeats in the VACV Genome Produce
Abundant vsiRNAs
As noted above, a significant fraction of the VACV vsiRNAs
map to the two genomic termini (Figure 7C, black arrows). Each
VACV genomic terminus is identical and contains tandem repeats
of a 70 nt element, with a total of 30 copies per terminus [25].
This region is devoid of open reading frames and instead is
thought to play a role in DNA replication [25]. Examination of the
vsiRNAs derived from these elements revealed that the majority
are 21 or 22 nt in length and align to a discrete region within the
70 nt repeat sequence (Figure S4B). Upon knockdown of Dcr-2,
but not Dcr-1, the most abundant 21 nt vsiRNA was depleted
(Figure S4C). In contrast, the most abundant 22 nt species appear
to require both Dcr-2 and Dcr-1 for biogenesis, since the 22 nt
vsiRNA levels are moderately depleted in both Dcr-2 and Dcr-1
deficient cells (Figure S4C). Loss of Ago2 led to a reduction in both
the 21 and 22 nt repeat-derived vsiRNAs, while Ago1 depletion
only affected the levels of the 22 nt species (Figure S4D). We
modeled the predicted secondary structure of one 70 nt repeat
using RNAfold, and mapped the most abundant 21 nt VACV
vsiRNA onto the structure (Figure 8A; red). The predicted
structure is a stem-loop reminiscent of a pre-miRNA; the VACV
vsiRNAs map to the stem region.
These in silico results suggested that transcription of the VACV
tandem repeats gives rise to long, structured RNAs that serve as
siRNA and miRNA pathway substrates. Indeed, we found that this
region is expressed in Drosophila and mammalian cells (Figure 8B).
Moreover, the 70-mers do not appear to be expressed individually
but instead are present in longer transcripts containing multiple
copies of the repeat, since products corresponding to at least 5
copies of the repeat can be amplified by RT-PCR (Figure 8B). The
role of this highly structured RNA that contains no known ORFs,
and how dicing of this transcript impacts poxvirus replication, is
unknown.
Discussion
The results of this study serve to reinforce the notion that
a diverse set of viral RNA structures are produced during
infection, and that cells are capable of differentially recognizing
and targeting these structures. Although the viruses in our panel
display striking differences in the spectrum of vsiRNAs produced
during infection, in each case the majority of the vsiRNAs are Dcr-
2 cleavage products. Therefore, Dcr-2 is the major nuclease,
recognizing and processing a wide range of substrates, an idea that
has recently been solidified by the discovery that endogenous, Dcr-
2-dependent siRNAs derive from a variety of precursors, including
structured RNAs and dsRNA formed during bidirectional
transcription [1]. However, in some cases, we found that the
levels of vsiRNAs were partially dependent on components of the
miRNA machinery as well as the siRNA pathway. For instance,
knockdown of Drosha or Ago1 leads to a slight increase in
vsiRNAs for several viruses (Figures 1, 5 and 7). An increase in
FHV vsiRNAs upon Ago1 depletion has also been observed by
Flynt and colleagues [27]. One hypothesis to explain these effects
is that the miRNA pathway normally represses expression of a pro-
viral factor. Impaired miRNA pathway function would therefore
lead to increased expression of the pro-viral factor, leading to
enhanced viral replication, which provides more viral RNA
substrates to the Dcr-2-driven RNAi pathway. Alternatively, cross-
loading of vsiRNAs into an active Ago1 complex, which is
a common fate for several endogenous siRNAs [28], might also
explain the increase in viral replication and vsiRNAs production in
the absence of Ago1. Cross-loading into Ago1 may also explain the
differential stability of VSV DI hairpin-derived vsiRNAs (Figure 2).
However, detailed future studies are necessary to dissect the role of
the miRNA pathway in vsiRNA biogenesis.
Our data demonstrate that the viral RNAs targeted by the
cellular RNAi machinery fall into several general categories
including dsRNA intermediates (RVFV L and M segments, VSV),
genomic RNAs (DCV), and unique, heavily targeted predicted
hairpins (RVFV S segment; VACV tandem repeats). Moreover,
the distribution pattern of vsiRNAs produced from viral dsRNA
can mirror the distribution observed from a synthetic dsRNA
bearing the same sequence (Figure 6). Thus, the vsiRNA levels that
we have characterized are governed, at least in part, by properties
of the RNAs themselves.
These findings complement and expand upon previous studies
examining arbovirus-derived vsiRNAs. Deep sequencing of
vsiRNAs from various mosquito species and mosquito-derived
cell lines has revealed that vsiRNAs produced from Sindbis virus,
Semliki Forest virus, and Dengue virus type 2 are present in
approximately equal ratios (,1.5:1 genome:antigenome) and are
distributed along the length of the genome [10,18,29]. These
patterns resemble our results for RVFV and VSV, suggesting that
the targeting of dsRNA replication intermediates is a common
mechanism of antiviral RNAi that is effective against multiple
arboviruses. In fact, a study by Mueller and colleagues previously
described vsiRNA profiles of VSV infection of adult flies; the
vsiRNAs map approximately equally to both strands, suggesting
that the viral replication intermediate is targeted [14]. These
results demonstrate that the antiviral RNAi pathway operates
similarly in Drosophila cells and adult flies, supporting the notion
that the observations made in cell culture reflect the function of the
RNAi pathway in vivo.
To our knowledge, this study is the first to investigate the
production of vsiRNAs from a DNA virus. Many mammalian
DNA viruses, most notably Herpesvirus family members, co-opt
host RNA silencing machinery in order to express virus-encoded
siRNA sequence are shown. (E) Partial autocorrelation functions of four sequences; exogenous LacZ, exogenous GFP, RVFV L segment, VSV nt 1–9000.
Dotted lines indicate the 95% significance level. Black arrows indicate additional regions of significant autocorrelation at 21 nt.
doi:10.1371/journal.pone.0055458.g006
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Figure 7. RNA transcripts produced by VACV are targeted by the Drosophila RNA silencing pathway. (A) The VACV genome is a dsDNA
molecule with covalently closed identical termini. (B) VACV vsiRNA size distribution (control library). (C) Distribution of 21 nt VACV vsiRNAs across the
viral genome. vsiRNAs mapping to the (+) strand are depicted in blue, (2) strand in red. Black arrows mark genomic termini. (D) VACV vsiRNA size
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miRNAs, which are transcribed as stem loop precursors and
require processing by the host miRNA biogenesis pathway [30].
VACV is not thought to encode viral miRNAs, since its exclusively
cytoplasmic replication precludes access to the nuclear miRNA
processing machinery. However, we identified virus-derived small
RNAs produced during VACV infection. The most prominent
group were derived from structured hairpins encoded by terminal
repeat sequences (Figure 8) and provide the first evidence for
putative VACV-encoded small RNAs that may play a regulatory
role during infection. We also identified additional hotspots which
have yet to be fully characterized. Given the large number of
insect-borne poxviruses [31], it is likely that poxviruses have
evolved strategies to harness or counteract insect RNA silencing
machinery. Indeed, we recently found that the VACV-encoded
poly(A)polymerase VP55 can target endogenous miRNAs for
degradation both in insects and mammals [32].
Another important facet of the antiviral RNAi response is the
ability of the virus to overcome the restrictive pressure placed on it
by the pathway. Thus, many pathogenic plant- and insect-specific
viruses encode suppressors of silencing [4]. Among the viruses
queried in this study, DCV is the only pathogenic insect virus, and
is known to carry DCV-1A, a protein suppressor of RNAi that
binds long dsRNA and reduces the accessibility of dsRNAs to Dcr-
2 [20]. The insect virus FHV also carries a suppressor, B2, which
binds siRNAs and long dsRNAs [4]. FHVDB2, a strain that does
not express B2, produces approximately equal (+) and (2) sense
distribution between libraries depleted of RNase III enzymes. (E) Effect of RNase III enzyme depletion on 21 nt VACV vsiRNAs. vsiRNAs from control
(black), Dcr-1 (orange), Dcr-2 (green) and Drosha (blue) depleted cells are compared. (F) VACV vsiRNA size distribution between libraries depleted of
Argonaute proteins. (G) Effect of Argonaute depletion on 21 nt VACV vsiRNAs. vsiRNAs from control (black), Ago1 (orange), and Ago2 (green)
depleted cells are compared. See also Figures S1, S2.
doi:10.1371/journal.pone.0055458.g007
Figure 8. VACV terminal repeat-derived vsiRNAs are derived from long, repeat-containing precursors. (A) RNA secondary structure
prediction of one of sixty 70-mer repeats located at the genomic termini. The abundant repeat-associated VACV vsiRNA is mapped in red. See also
Figure S4. (B) Expression analysis of VACV terminal repeat-associated transcripts in Drosophila DL1 cells and mouse embryonic fibroblasts (MEFs) by
RT-PCR. The forward primer (red) lies within the 70-mer repeat sequence, while the reverse primer (green) binds a unique sequence outside of the
repetitive region. The banding pattern of PCR products reflects the amplification of variable numbers of 70-mer repeats, as depicted in the diagram.
M=DNA ladder.
doi:10.1371/journal.pone.0055458.g008
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vsiRNAs in wild-type flies and cells [23,27,33]. However, the
vsiRNAs produced during wild-type FHV infection of wild-type
flies are heavily skewed toward the genomic strand [22,23], similar
to our results with DCV (Figures 5–6). Interestingly, we and others
have found that West Nile virus (WNV), a human arbovirus, also
displays a vsiRNA distribution that is skewed toward the genomic
strand [7] (Sabin and Cherry, unpublished observations). Consis-
tently, a putative RNA-based suppressor of dicing, encoded within
the WNV 39 UTR, was recently identified [34]. This supports the
hypothesis that in the presence of an RNAi suppressor that impairs
the pathway at the level of dicing, vsiRNAs are skewed towards the
genomic RNA strand, which is more abundant than the minus
strand.
Although many insect viruses encode protein suppressors of
RNA silencing, such as DCV-1A, our identification of unique,
heavily targeted RNAs such as the VSV DI particles (Figure 2) and
the putative RVFV S segment intergenic hairpin (Figure 4) raises
the possibility that some viruses may employ RNA decoys as
a mechanism to evade the antiviral RNAi machinery. It will
therefore be of interest to compare the role of the RVFV hairpin
in mammalian versus insect infections, since the mammalian
RNAi pathway is not intrinsically antiviral. In the case of VSV, the
DI snapback particles may serve as an RNA decoy to direct Dcr-2
activity away from genome targeting. Since the DI hairpins are
targeted by Dcr-2, but the resulting vsiRNAs are not stabilized by
Ago2 (Figure 2B), they likely cannot target RISC to viral
transcripts. Thus, a redirection of Dcr-2 to process substrates that
will not go on to degrade additional viral RNAs may allow the
virus to partially evade the antiviral activity of the siRNA pathway.
These findings are supported by the study by Mueller et al., which
found that when high levels of VSV replication were achieved in
AGO2-deficient flies, creating a favorable condition for DI particle
formation, a preference for 59 end targeting was observed [14].
However, in wild type cells or flies with lower levels of infection,
that disfavor the production of DI particles, the vsiRNA
distribution was even across the genome [14]. This suggests that
the over-replication of DI particles represents an active immune
evasion strategy for VSV. By diverting recognition and cleavage to
decoy transcripts, a virus may reduce the efficiency of pathway
targeting of other essential viral RNAs. Therefore, RNAi pathway
impairment using RNA decoys could operate as a novel nucleic
acid-based immune evasion mechanism in insects, serving as an
additional layer of host antagonism by viral pathogens.
Materials and Methods
Cells and Viruses
Drosophila DL1 cells were grown and maintained as previously
described [35]. Aedes aegypti Aag2 cells [36] were grown and
maintained at 25uC in complete Schneider’s Drosophila media
(Gibco). Aedes albopictus C6/36 cells were obtained from ATCC,
grown and maintained at 25uC in L-15 medium (Gibco). Mouse
embryonic fibroblasts (MEFs) [26] were grown in DMEM (Gibco).
RVFV strain MP12 was grown in Vero cells [37]. VSV-eGFP (gift
from J. Rose) was grown in BHK cells as described [38]. DCV was
grown and purified as described [35]. Vaccinia strain vPRA13 was
grown in HeLa S3 suspension cells [39].
RNAi and Viral Infections
RNAi was performed as previously described [12]. Cells were
infected for 4 days as follows: DCV MOI=7; RVFV MOI= 17;
VACV MOI=383; VSV MOI= 4. Aag2 and C6/36 cells were
infected with RVFV MOI= 12.5 for 4 days. MEFs were infected
with VACV MOI=1 for 8 hours.
RNA Analysis
Total RNA was extracted and analyzed by traditional northern
blotting, small RNA northern blotting and RT-PCR as previously
described [12]. Knockdown of RNAi machinery was quantified
using a SYBRGreen (Applied Biosystems)-based qPCR assay using
oligodT-primed cDNA. Oligonucleotide probes and primers are
listed in Supporting Information.
Small RNA Library Generation
40 mg of total RNA was separated on a 15% TBE-urea gel and
small RNAs ,15–29 nt were excised and eluted. Following
ethanol precipitation, small RNA-seq libraries were produced
using the Small RNA Sample Prep v1.5 kit (Illumina, San Diego,
CA) as per manufacturer’s instructions.
Accession Numbers
All raw small RNA sequence data was deposited in Gene
Expression Omnibus (GEO) under the accession GSE43031. This
includes 24 total sequence datasets that include control as well as
Dcr-1, Dcr-2, Drosha, Ago1, and Ago2 knockdowns for all four
viruses.
Bioinformatics and Computational Analysis
Detailed descriptions of small RNA mapping procedures and
vsiRNA profile generation are found in Supporting Information.
The genomic location of individual vsiRNAs or siRNAs relative to
viral genomes or synthetic dsRNAs are found in Tables S1, S2, S3,
S4, and S5. Time series analyses were performed with the R
environment [40], and autocorrelation analysis was performed
with the MASS package [24].
Supporting Information
Figure S1 Related to Figures 1, 3, 5, and 7. Distribution
of non-21 nt vsiRNAs across viral genomes. (A) Distribu-
tion of non-21 nt (between 15 and 29 nt) VSV-derived vsiRNAs
(control LacZ-depleted library) across the viral genome. vsiRNAs
mapping to genomic strand are depicted in blue, antigenomic
strand in red. (B) Distribution of non-21 nt (between 15 and 29 nt)
DCV-derived vsiRNAs (control LacZ-depleted library) across the
viral genome. vsiRNAs mapping to genomic strand are depicted in
blue, antigenomic strand in red. (C) Distribution of non-21 nt
(between 15 and 29 nt) VACV-derived vsiRNAs (control GFP-
depleted library) across the viral genome. vsiRNAs mapping to the
(+) strand are depicted in blue, (2) strand in red. (D) Distribution
of non-21 nt (between 15 and 29 nt) RVFV-derived vsiRNAs
(control LacZ-depleted library) across the viral genome. vsiRNAs
mapping to genomic strand are depicted in blue, antigenomic
strand in red.
(TIF)
Figure S2 Related to Figures 1, 3, 5, and 7. miRNA and
siRNA pathway components are depleted by RNAi. (A)
Robust loss-of-function phenotypes were verified by small RNA
northern blotting of RNA samples used to create small RNA
libraries. Loss of miRNA pathway components (left panel) affected
steady-state levels of bantam miRNA (mature and pre-miRNA
forms), while loss of siRNA pathway components resulted in
a depletion of the endogenous siRNA esi-2.1. Equal loading was
verified by probing 2S rRNA. (B) OligodT-primed cDNA from
cells depleted of the indicated RNA silencing factor was subjected
to PCR and quantified relative to Rp49 levels. Data is expressed as
the normalized mRNA expression in the depleted cells compared
to the control cells bathed in a non-targeting dsRNA (LacZ). A
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representative experiment is shown. Error bars indicate standard
deviation.
(TIF)
Figure S3 Related to Figure 2. Detection of VSV mRNA
and putative DI hairpin RNAs. Northern blot from Figure 2,
probed for various VSV-derived RNA species, which now includes
a longer exposure of the rightmost panel in order to better
visualize the low-abundance VSV-L mRNA species (,6 kb),
indicated by arrow.
(TIF)
Figure S4 Related to Figure 8. VACV terminal repeat-
derived siRNA biogenesis and Argonaute stabilization.
(A) vsiRNAs produced from a ‘‘hot spot’’ region may be generated
due to bidirectional transcription, which generates complementary
RNAs with the potential to base pair and form a dsRNA target of
the RNAi machinery. A VACV vsiRNA ‘‘hot spot’’ region is
highlighted in orange, and the two VACV genes that could
potentially produce overlapping, bidirectional transcripts are
diagrammed in green. (B) The most abundant repeat-derived
vsiRNAs of each size class are diagrammed in reference to the
terminal repeat sequence, shown in green. Their relative
abundance is calculated as a percentage of all repeat-derived
vsiRNAs with .10 reads cloned in the control library. (C)
Quantification of the abundant vsiRNAs described in (A) upon
Dcr-1 and Dcr-2 depletion. (D) Quantification of the abundant
vsiRNAs described in (A) upon Ago1 and Ago2 depletion.
(TIF)
Table S1 Related to Figure 1. Start location, end location,
size, copy number, mismatches and strand for VSV vsiRNA
libraries.
(XLSB)
Table S2 Related to Figure 3. Start location, end location,
size, copy number, mismatches and strand for RVFV vsiRNA
libraries.
(XLSB)
Table S3 Related to Figure 5. Start location, end location,
size, copy number, mismatches and strand for Control, Dcr-2, and
Ago2 DCV vsiRNA libraries.
(XLSB)
Table S4 Related to Figure 5. Start location, end location,
size, copy number, mismatches and strand for Drosha, Dcr-1 and
Ago1 DCV vsiRNA libraries.
(XLSB)
Table S5 Related to Figure 7. Start location, end location,
size, copy number, mismatches and strand for VACV vsiRNA
libraries.
(XLSB)
Text S1 Supporting experimental procedures.
(DOCX)
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